4//SEC Filing
Walker Marlan D 4
Accession 0000905148-25-000737
CIK 0000025743other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:07 PM ET
Size
17.8 KB
Accession
0000905148-25-000737
Insider Transaction Report
Form 4
Walker Marlan D
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+3,467→ 66,032 total - Exercise/Conversion
Common Stock
2025-02-18+2,311→ 68,343 total - Exercise/Conversion
Common Stock
2025-02-18+770→ 69,113 total - Exercise/Conversion
Common Stock
2025-02-18+1,733→ 70,846 total - Exercise/Conversion
Performance Stock Units
2025-02-18−3,467→ 0 totalExercise: $0.00→ Common Stock (3,467 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-18−2,311→ 0 totalExercise: $0.00→ Common Stock (2,311 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-18−770→ 0 totalExercise: $0.00→ Common Stock (770 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-18−1,733→ 1,733 totalExercise: $0.00→ Common Stock (1,733 underlying)
Footnotes (4)
- [F1]Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.
- [F3]Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.
- [F4]Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001820187
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:07 PM ET
- Size
- 17.8 KB